NCT07216001View on ClinicalTrials.gov

Role of Omega-DEK in Childhood Apraxia of Speech

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Childhood Apraxia of SpeechVerbal ApraxiaAutism
Interventions
DRUG

Omega-DEK

Participants take 2 capsules, twice daily (BID).

DRUG

L-carnitine

Participants take 250 mg L-carnitine administered as a 2.5 mL oral solution twice daily (BID). L-carnitine is provided to participants only during the 12-week open-label trial.

DRUG

Placebo

A placebo of palm kernel oil to match Omega-DEK is provided. Participants take 2 capsules, twice daily (BID).

Trial Locations (2)

30322

Children's Healthcare of Atlanta, Atlanta

30329

Marcus Autism Center, Atlanta

All Listed Sponsors
lead

Claudia R. Morris

OTHER